| Address : FIVE MOORE DRIVE RESEARCH TRIANGLE PARK, NC, 27709-3398 UNITED STATES | |||
| Status : A | Type : A | Woman Owned : N | Business Type : N |
| Business Size : E | Primary Business : J | CAO Code : S5111A | ADP Code : HQ0338 |
| Manufacturer: Glaxowellcome | |||
| Part Number | Item Name | Manufacturer | NSN | RFQ |
|---|---|---|---|---|
| NDC61570-0047-10 | neomycin and polymy | Glaxowellcome | 6505-01-224-6361 | RFQ |
| NDC60976-0347-47 | labetalol hydrochloride tablets usp | Glaxowellcome | 6505-01-319-5117 | RFQ |
| NDC60976-0346-47 | labetalol hydrochloride tablets usp | Glaxowellcome | 6505-01-218-7436 | RFQ |
| NDC58160-0856-35 | hepatitis b virus v | Glaxowellcome | 6505-01-492-5683 | RFQ |
| NDC58160-0842-46 | tetanus toxoid redu | Glaxowellcome | 6505-01-537-5486 | RFQ |
| NDC19515-0893-07 | influenza virus vaccine usp | Glaxowellcome | 6505-01-627-2699 | RFQ |
| NDC12593-0106-1 | propyliodone inject | Glaxowellcome | 6505-00-685-5554 | RFQ |
| NDC00173-0991-56 | acyclovir capsules | Glaxowellcome | 6505-01-206-9245 | RFQ |
| NDC00173-0945-55 | acyclovir tablets u | Glaxowellcome | 6505-01-341-9964 | RFQ |
| NDC00173-0933-56 | valacyclovir hydroc | Glaxowellcome | 6505-01-455-4230 | RFQ |
| NDC00173-0748-10 | neomycin and polymy | Glaxowellcome | 6505-01-224-6361 | RFQ |
| NDC00173-0719-20 | fluticasone propion | Glaxowellcome | 6505-01-532-6924 | RFQ |
| NDC00173-0543-01 | cisatracurium besylate injection | Glaxowellcome | 6505-01-434-0941 | RFQ |
| NDC00173-0465-00 | salmeterol xinafoat | Glaxowellcome | 6505-01-388-9527 | RFQ |
| NDC00173-0461-00 | ondansetron hydrochloride in dextrose injection | Glaxowellcome | 6505-01-417-9964 | RFQ |
| NDC00173-0449-02 | sumatriptan succina | Glaxowellcome | 6505-01-374-5874 | RFQ |
| NDC00173-0447-04 | ondansetron hydrochloride tablets | Glaxowellcome | 6505-01-374-5868 | RFQ |
| NDC00173-0442-00 | ondansetron hydroch | Glaxowellcome | 6505-01-336-6184 | RFQ |
| NDC00173-0430-00 | fluticasone propion | Glaxowellcome | 6505-01-387-7607 | RFQ |
| NDC00173-0424-00 | cefuroxime sodium i | Glaxowellcome | 6505-01-317-1109 | RFQ |
| NDC00173-0423-01 | oxiconazole nitrate | Glaxowellcome | 6505-01-315-5326 | RFQ |
| NDC00173-0417-00 | ceftazidime for injection usp | Glaxowellcome | 6505-01-336-6183 | RFQ |
| NDC00173-0415-00 | ceftazidime for inj | Glaxowellcome | 6505-01-337-0318 | RFQ |
| NDC00173-0413-00 | ceftazidime sodium | Glaxowellcome | 6505-01-323-2649 | RFQ |
| NDC00173-0402-06 | alclometasone dipropionate ointment usp | Glaxowellcome | 6505-01-387-6732 | RFQ |
| NDC00173-0402-01 | alclometasone dipropionate ointment usp | Glaxowellcome | 6505-01-315-5327 | RFQ |
| NDC00173-0401-01 | alclometasone dipropionate cream usp | Glaxowellcome | 6505-01-314-7931 | RFQ |
| NDC00173-0393-47 | ranitidine tablets | Glaxowellcome | 6505-01-230-6240 | RFQ |
| NDC00173-0388-79 | beclomethasone dipr | Glaxowellcome | 6505-01-275-4811 | RFQ |
| NDC00173-0378-35 | ceftazidime for inj | Glaxowellcome | 6505-01-227-3570 | RFQ |
| NDC00173-0376-72 | clobetasol propiona | Glaxowellcome | 6505-01-229-9095 | RFQ |
| NDC00173-0375-01 | clobetasol propiona | Glaxowellcome | 6505-01-309-2745 | RFQ |
| NDC00173-0363-39 | ranitidine injectio | Glaxowellcome | 6505-01-206-0278 | RFQ |
| NDC00173-0353-32 | cefuroxime sodium usp | Glaxowellcome | 6505-01-238-5629 | RFQ |
| NDC00173-0352-30 | cefuroxime sodium u | Glaxowellcome | 6505-01-200-5784 | RFQ |
| NDC00173-0348-43 | labetalol hydrochlo | Glaxowellcome | 6505-01-197-4180 | RFQ |
| NDC00173-0347-44 | labetalol hydrochlo | Glaxowellcome | 6505-01-208-5995 | RFQ |
| NDC00173-0346-47 | labetalol hydrochloride tablets usp | Glaxowellcome | 6505-01-218-7436 | RFQ |
| NDC00173-0346-43 | labetalol hydrochlo | Glaxowellcome | 6505-01-218-7438 | RFQ |
| NDC00173-0346-43 | labetalol hydrochlo | Glaxowellcome | 6505-01-237-0557 | RFQ |
| NDC00173-0344-14 | ranitidine tablets | Glaxowellcome | 6505-01-387-6730 | RFQ |
| NDC00173-0312-88 | beclomethasone dipr | Glaxowellcome | 6505-01-028-9707 | RFQ |
| NDC00173-0281-43 | ethaverine hydrochl | Glaxowellcome | 6505-00-767-5675 | RFQ |
| NDC00173-0249-80 | digoxin tablets usp | Glaxowellcome | 6505-01-153-3236 | RFQ |
| NDC00173-0242-56 | digoxin tablets usp | Glaxowellcome | 6505-01-212-4350 | RFQ |
| NDC00173-0230-44 | digoxin immune fab for injection | Glaxowellcome | 6505-01-273-1798 | RFQ |
| NDC00173-0177-55 | bupropion hydrochlo | Glaxowellcome | 6505-01-314-6641 | RFQ |
| NDC00173-0135-55 | bupropion hydrochlo | Glaxowellcome | 6505-01-498-3167 | RFQ |
| NDC00173 0546 00 | cisatracurium besylate injection | Glaxowellcome | 6505-01-434-0317 | RFQ |
| NCD00173-0434-00 | ceftazidime for injection usp | Glaxowellcome | 6505-01-285-7473 | RFQ |
![]() |
AS9120B and ISO 9001:2015 |
![]() |
Aviation Suppliers Association Member |
![]() |
FAA AC 0056B Accredited |
![]() |
AS 6081:2012 Certification |
![]() |
ESD S20.20-2014 Certification |
Don’t forget That We offer 24/7 Service, Competitive Prices, and Fast Deliveries. We Hope You'll Make Us Your One-Stop Purchasing Solution!
Request for Quote